MARKET

AGIO

AGIO

Agios Pharmaceuticals Inc
NASDAQ
24.75
-0.02
-0.08%
After Hours: 24.75 0 0.00% 18:06 09/29 EDT
OPEN
24.97
PREV CLOSE
24.77
HIGH
25.21
LOW
24.50
VOLUME
439.06K
TURNOVER
0
52 WEEK HIGH
31.87
52 WEEK LOW
21.07
MARKET CAP
1.38B
P/E (TTM)
-6.5149
1D
5D
1M
3M
1Y
5Y
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
NASDAQ · 2d ago
Here's Why We're Not Too Worried About Agios Pharmaceuticals' (NASDAQ:AGIO) Cash Burn Situation
Simply Wall St · 3d ago
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
NASDAQ · 3d ago
Noteworthy Monday Option Activity: MU, AGIO, AMR
NASDAQ · 4d ago
Weekly Report: what happened at AGIO last week (0918-0922)?
Weekly Report · 4d ago
Weekly Report: what happened at AGIO last week (0911-0915)?
Weekly Report · 09/18 09:03
Weekly Report: what happened at AGIO last week (0904-0908)?
Weekly Report · 09/11 09:03
Weekly Report: what happened at AGIO last week (0828-0901)?
Weekly Report · 09/04 09:27
More
About AGIO
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of a- and b-thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD and anemia associated with low-to intermediate-risk myelodysplastic syndrome (LR MDS), and hemolytic anemias.

Webull offers kinds of Agios Pharmaceuticals Inc stock information, including NASDAQ:AGIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGIO stock methods without spending real money on the virtual paper trading platform.